OSIRIS Therapeutics, Inc.

Baltimore, Maryland

Biotechnology Company engaged in the development of cellular transplants and cell matrix products for the treatment of soft tissue and bone disorders.

Services included:

• Conversion of 30,000 SF warehouse into a state-of-the-art bio-technology pharmaceutical research and development facility.
• Design of 1,200 SF cGMP Pilot Plant housing class 10,000 and class 1000 engineered cleanrooms.
• New 1,000 SF sterility class 10,000 and 100,000 cGMP manufacturing clean space.
• New 10,000 SF cGMP Facility.

Website: www.osiristx.com